With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.
One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.
The financial opportunity within the bacteriophagetherapeutics market has been analyzed across the following segments:
The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
Table of Content
4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE
5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE
12. PARTNERSHIPS AND COLLABORATIONS
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html
You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market
You may also like to learn what our experts are sharing in Roots educational series:
T-cell Immunotherapies: The Future of Modern Cancer Treatments
Monkeypox: Disease Overview, Transmission and Diagnosis
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#Bacteriophagetherapeuticsmarket #Bacteriophagetherapeuticsmarketsize #bacteriophage #phage# bacteriophagetherapy